Drug Therapy in Adult Congenital Heart Disease

Tahmeed Contractor; Vadim Levin; Ravi Mandapati

doi:10.1016/j.ccep.2017.02.011

Drug Therapy in Adult Congenital Heart Disease

Research output: Contribution to journal › Article › peer-review

Abstract

Adults with congenital heart disease are at risk for atrial and ventricular arrhythmias that can lead to an increased morbidity as well as mortality. When catheter ablation is not an option or unsuccessful, antiarrhythmic drugs are the mainstay of treatment. There is limited data on the use of antiarrhythmics in this population. The purpose of this article is to discuss the practical aspects of the use of antiarrhythmics in adults with congenital heart disease. Several tables have been provided to provide clinicians a reference for daily use.

Original language	English
Pages (from-to)	295-309
Number of pages	15
Journal	Cardiac Electrophysiology Clinics
Volume	9
Issue number	2
DOIs	https://doi.org/10.1016/j.ccep.2017.02.011
State	Published - Jun 2017

ASJC Scopus Subject Areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Keywords

Anticoagulation
Arrhythmia
Congenital heart disease
Drug therapy
Anticoagulants/administration & dosage
Heart Defects, Congenital/drug therapy
Anti-Arrhythmia Agents/administration & dosage
Humans
Arrhythmias, Cardiac/drug therapy
Adult

Access to Document

10.1016/j.ccep.2017.02.011

OpenUrl availability

Full text

Cite this

@article{7521f87efdb4451e8dd68f386d3f0922,

title = "Drug Therapy in Adult Congenital Heart Disease",

abstract = "Adults with congenital heart disease are at risk for atrial and ventricular arrhythmias that can lead to an increased morbidity as well as mortality. When catheter ablation is not an option or unsuccessful, antiarrhythmic drugs are the mainstay of treatment. There is limited data on the use of antiarrhythmics in this population. The purpose of this article is to discuss the practical aspects of the use of antiarrhythmics in adults with congenital heart disease. Several tables have been provided to provide clinicians a reference for daily use.",

keywords = "Anticoagulation, Arrhythmia, Congenital heart disease, Drug therapy, Anticoagulants/administration \& dosage, Heart Defects, Congenital/drug therapy, Anti-Arrhythmia Agents/administration \& dosage, Humans, Arrhythmias, Cardiac/drug therapy, Adult",

author = "Tahmeed Contractor and Vadim Levin and Ravi Mandapati",

note = "Publisher Copyright: {\textcopyright} 2017 Elsevier Inc.",

year = "2017",

month = jun,

doi = "10.1016/j.ccep.2017.02.011",

language = "English",

volume = "9",

pages = "295--309",

journal = "Cardiac Electrophysiology Clinics",

issn = "1877-9182",

number = "2",

}

TY - JOUR

T1 - Drug Therapy in Adult Congenital Heart Disease

AU - Contractor, Tahmeed

AU - Levin, Vadim

AU - Mandapati, Ravi

PY - 2017/6

Y1 - 2017/6

N2 - Adults with congenital heart disease are at risk for atrial and ventricular arrhythmias that can lead to an increased morbidity as well as mortality. When catheter ablation is not an option or unsuccessful, antiarrhythmic drugs are the mainstay of treatment. There is limited data on the use of antiarrhythmics in this population. The purpose of this article is to discuss the practical aspects of the use of antiarrhythmics in adults with congenital heart disease. Several tables have been provided to provide clinicians a reference for daily use.

AB - Adults with congenital heart disease are at risk for atrial and ventricular arrhythmias that can lead to an increased morbidity as well as mortality. When catheter ablation is not an option or unsuccessful, antiarrhythmic drugs are the mainstay of treatment. There is limited data on the use of antiarrhythmics in this population. The purpose of this article is to discuss the practical aspects of the use of antiarrhythmics in adults with congenital heart disease. Several tables have been provided to provide clinicians a reference for daily use.

KW - Anticoagulation

KW - Arrhythmia

KW - Congenital heart disease

KW - Drug therapy

KW - Anticoagulants/administration & dosage

KW - Heart Defects, Congenital/drug therapy

KW - Anti-Arrhythmia Agents/administration & dosage

KW - Humans

KW - Arrhythmias, Cardiac/drug therapy

KW - Adult

UR - https://www.scopus.com/pages/publications/85018245119

UR - https://www.scopus.com/pages/publications/85018245119#tab=citedBy

UR - https://www.mendeley.com/catalogue/bd04f4b8-c5b0-31aa-86c4-9a9140d71eeb/

U2 - 10.1016/j.ccep.2017.02.011

DO - 10.1016/j.ccep.2017.02.011

M3 - Article

C2 - 28457243

SN - 1877-9182

VL - 9

SP - 295

EP - 309

JO - Cardiac Electrophysiology Clinics

JF - Cardiac Electrophysiology Clinics

IS - 2

ER -

Drug Therapy in Adult Congenital Heart Disease

Abstract

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this